Johnson & Johnson mentioned late Thursday that its single-shot COVID-19 vaccine generated sturdy, constant exercise towards Delta and different extremely prevalent variants.
The knowledge confirmed that the permanence of the immune response lasted at the least eight months, the US-based healthcare firm mentioned, including that its vaccine was 85% efficient and will additionally assist stop hospitalization and demise. is.
“The current eight months of data studied so far suggest that the single-shot Johnson & Johnson COVID-19 vaccine produces a strong neutralizing antibody response that does not subside; Rather, we see improvement over time,” mentioned Mathai Maimon, head of analysis and growth at J&J’s medicine enterprise.
The firm mentioned the COVID-19 vaccine produced neutralizing antibody exercise towards the delta variant, which was first recognized in India, which was even increased than the extent seen for the beta variant, which was first detected in South Africa. I went.
J&J has submitted the information as a preprint to the web site bioRxiv prior to look evaluation.
.
With inputs from TheIndianEXPRESS
